These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30949254)

  • 1. Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.
    Shibahara T
    Jpn Dent Sci Rev; 2019 Nov; 55(1):71-75. PubMed ID: 30949254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
    Yuan A; Munz A; Reinert S; Hoefert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.
    Kim KM; Rhee Y; Kwon YD; Kwon TG; Lee JK; Kim DY
    J Bone Metab; 2015 Nov; 22(4):151-65. PubMed ID: 26713306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.
    Yang G; Williams R; Wang L; Farhadfar N; Chen Y; Loiacono AT; Bian J; Holliday LS; Katz J; Gong Y
    J Bone Miner Res; 2022 Dec; 37(12):2466-2471. PubMed ID: 36151778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw.
    Wat WZM
    Dent J (Basel); 2016 Oct; 4(4):. PubMed ID: 29563480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study.
    Seki K; Kaneko T; Kamimoto A; Wada M; Takeuchi Y; Furuchi M; Iinuma T
    J Dent Sci; 2022 Oct; 17(4):1619-1625. PubMed ID: 36299343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).
    Aguirre JI; Castillo EJ; Kimmel DB
    Bone; 2021 Dec; 153():116184. PubMed ID: 34520898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database.
    Inada A; Hosohata K; Oyama S; Niinomi I; Mori Y; Yamaguchi Y; Uchida M; Iwanaga K
    Ther Clin Risk Manag; 2019; 15():59-64. PubMed ID: 30636879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events.
    Nakamura M; Umetsu R; Abe J; Matsui T; Ueda N; Kato Y; Sasaoka S; Tahara K; Takeuchi H; Kinosada Y
    J Pharm Health Care Sci; 2015; 1():34. PubMed ID: 26819745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current situation and future issues of antiresorptive agent-related osteonecrosis of the jaw].
    Takaoka K; Kishimoto H
    Nihon Yakurigaku Zasshi; 2019; 153(1):22-27. PubMed ID: 30643088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.
    Kim JW; Kwak MK; Han JJ; Lee ST; Kim HY; Kim SH; Jung J; Lee JK; Lee YK; Kwon YD; Kim DY
    J Bone Metab; 2021 Nov; 28(4):279-296. PubMed ID: 34905675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.
    Rosella D; Papi P; Giardino R; Cicalini E; Piccoli L; Pompa G
    J Int Soc Prev Community Dent; 2016; 6(2):97-104. PubMed ID: 27114946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Percutaneous Controlled Radiofrequency Thermocoagulation of the Gasserian Ganglion To Control Facial Pain Due to Medication-Related Osteonecrosis of the Jaw.
    Taniguchi A; Fukazawa K; Hosokawa T
    J Palliat Med; 2017 Oct; 20(10):1171-1174. PubMed ID: 28772087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease.
    Sivolella S; Lumachi F; Stellini E; Favero L
    Anticancer Res; 2013 May; 33(5):1793-7. PubMed ID: 23645723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.